Cardio Pharma Corp (COM.TO) Buy, Sell or Hold

Cardio Pharma Corp (COM.TO)

0.00

-0.00 (0.00%)

0 watching

PAST TOP PICK

(A Top Pick Nov 20/06. Down 27%.) Has a nice little product and they are going through their trials and there is the talk of being a takeout. However, the market just doesn't care. Sold his holdings.

TOP PICK

There were concerns on FDA approval, but he feels these are not major and the drug is good. Expect it will be taken over.

BUY

Have some excellent drugs. Data is coming out which they hope will be very good in the next 3/6 months.

DON'T BUY

Had some interesting trial data. Shares have moved up quite nicely, but now priced with good news built-in. Fully valued.

BUY

Has something that is very competitive in arrhythmia. A good one to take a look at.

Showing 1 to 5 of 5 entries

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

Cardio Pharma Corp (COM.TO) Frequently Asked Questions

What is Cardio Pharma Corp stock symbol?

Cardio Pharma Corp is a OTC stock, trading under the symbol COM.TO (previously COM-T on Stockchase) on the undefined (undefined). It is usually referred to as or COM.TO

Is Cardio Pharma Corp a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on COM.TO (previously COM-T on Stockchase) on Stockchase. Read the latest expert commentary for Cardio Pharma Corp.

Is Cardio Pharma Corp a good investment or a top pick?

Cardio Pharma Corp was recommended as a Top Pick by Michael Smedley on 2003-09-30. Read the latest stock experts ratings for Cardio Pharma Corp.

Why is Cardio Pharma Corp stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Cardio Pharma Corp.

Is Cardio Pharma Corp worth watching?

Cardio Pharma Corp is covered by Stockchase experts and is worth watching.

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Richard Orrell

RN Croft Financial Group

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Private Wealth Management, ScotiaMcleod

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Cardio Pharma Corp (COM.TO)